Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thromboembolism × isoquercitrin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism of Vein VTE in Colorectal Cancer 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1

Interventions

Tinzaparin 3 Gemcitabine 3 Heparin, Low-Molecular-Weight 2 Enoxaparin 2 Dalteparin 2 130-nm albumin-bound paclitaxel 2 palbociclib 1 isoquercitrin 1 Watchful Waiting 1 Rivaroxaban 1 PEGPH20 1 High-Energy Shock Waves 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06861088 2026-02-02

CATIQ P3

Quercis Pharma AG

Phase 3 Recruiting

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡